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Abstract
Background: Bermuda grass (Cynodon dactylon; subfamily Chloridoideae) is an important source
of seasonal aeroallergens in warm tropical and sub-tropical areas worldwide. Improved approaches
to diagnosis and therapy of allergic diseases require a thorough understanding of the structure and
epitopes on the allergen molecule that are crucial for the antigen-antibody interaction. This study
describes the localization of the human IgE-binding regions of the major group 1 pollen allergen Cyn
d 1 from Bermuda grass.
Methods: A cDNA library was constructed from Bermuda grass pollen (BGP) using a Lambda gt11
expression vector. The gene encoding the Cyn d 1 allergen was isolated by screening the library
with a mouse monoclonal antibody raised against grass group 1 allergen. In order to characterize
the IgE epitopes on Cyn d 1, seven overlapping fragments and three deletion mutants were cloned
and over-expressed in E. coli. The recombinant fragments and deletion mutants were evaluated for
their comparative IgE reactivity with sera of non atopic individuals and grass pollen allergic patients
by ELISA and a dot-blot assay.
Results: Analysis of IgE binding regions by overlapping fragments and deletion mutants identified
two major allergenic regions corresponding to amino acids 120–170 and 224–244. Deletion of
either or both regions led to a significant reduction in IgE binding, emphasizing the importance of
the C-terminal region on Cyn d 1 in epitope-IgE interaction.
Conclusion: Anti-Cyn d 1 IgE antibodies from allergic human sera recognize two epitopes located
at the C-terminal end of the molecule. These data will enable the design of improved diagnostic and
therapeutic approaches for BGP hypersensitivity.
Background
It is estimated that up to 20% of the population in devel-
oped countries suffers from atopic diseases caused by air-
borne allergens derived from grass and tree pollen, house
dust mites and animal dander, which has a significant
impact on quality of life and economic consequences
[1,2]. The role of grass pollen allergens in triggering
immunoglobulin E (IgE)-mediated type I allergic diseases,
such as allergic rhinitis, conjunctivitis, and bronchial
asthma is very well established [3,4]. Epidemiologic stud-
ies have revealed that allergies to Bermuda grass (Cynodon
dactylon; subfamily Chloridoideae) mainly affect people
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in warm tropical and sub-tropical areas of the world, such
as southwestern United States, South Africa and northern
and central Australia. Furthermore, approximately 27% of
asthmatic patients in Taiwan are reported to have a hyper-
sensitive response to crude Bermuda grass pollen (BGP)
extract [5].
Cyn d 1, the major allergen of BGP, is the most abundant
protein component of BGP, comprising 15–20% of crude
pollen extract. It dominates the human IgE response with
87% of individuals allergic to BGP showing positive reac-
tion to this 32 kDa protein [6,7]. Clinical evidence of
cross-reactivity among grass pollens has suggested that
diagnosis and effective immunotherapy can be achieved
with a limited number of grasses, although the selection
of species to treat against is based on regional prevalence
and taxonomic relationship. Grass group 1 allergens, with
molecular weights in the range of 31–35 kDa, are recog-
nized as one of the most prominent allergenic compo-
nents of pollen extracts. In recent years, the genes
encoding Group 1 allergens for several grasses have been
cloned and expressed using molecular biology techniques
[8,9]. When translated, the cDNA sequences predict pro-
teins of approximately 240 amino acid residues and
molecular weights of about 26 kDa. They share an N-gly-
cosylation site at amino acid position 9 and carry glycans
that account for 4–5% of their molecular weight. These
glycoproteins are located in the cytoplasm of the pollen
grain and are rapidly released when hydrated upon con-
tact with moist mucosal surfaces. A characteristic feature
of group 1 allergens is the presence of seven strictly con-
served cysteine residues, located mainly in the N-terminus
of the protein [10-12].
The first full length cDNA coding for Cyn d 1 was identi-
fied by Smith et al [11] followed by Chang et al [12]. Au
and colleagues have suggested the existence of two groups
of Cyn d 1, the acidic and the basic. The Cyn d 1 cDNAs
belonging to the basic group have N-terminal sequences
of AIGDKPNITATYGSKWLE, while the sequences of
acidic isoallergens showed substitutions of M, D, L, D for
I, S, K, E (italicised in the aforementioned sequence),
respectively [13].
Comparison of amino acid sequences of group 1 allergens
reveals a high degree of sequence similarity, which high-
lights a possible basis of allergenic cross-reactivity
observed among group 1 allergens when investigated by
inhibition techniques among taxonomically related
grasses [14-16]. However, earlier studies on allergens from
BGP have shown that BGP allergens share minimal IgE
cross-reactivity with pollen from Poaceae sub-family
grasses, such as Dactylis glomerata, Lolium perenne, Festuca
pratensis, Phleum pratense and Poa pratensis when tested
with crude pollen extracts. These findings suggest the pres-
ence of unique IgE epitopes in BGP allergens [17,18]. In a
recent study, twenty specific anti-Phl p 1 monoclonal anti-
bodies (MAbs) were produced from BALB/c mice immu-
nized with natural Phl p 1. When tested for specificity
with thirteen different grass pollen extracts, eighteen to
nineteen anti-Phl p 1 MAbs recognized the homologous
allergen in pollen extracts from grasses of the Poeae tribe
while only four MAbs recognized the group 1 allergen
from Cynodon dactylon [19]. These studies further suggest
that the antigenic regions of Cyn d 1 in BGP may be dif-
ferent from Poeae grasses, and as a result, individuals
allergic to BGP may require separate diagnosis and ther-
apy.
Recombinant allergens are useful tools for structural anal-
ysis, including that of IgE binding epitopes, and may pro-
vide a better understanding of the allergic immune
response. Although allergenic properties and IgE epitopes
from Poaeae grasses have been studied extensively [20-
22], information on the IgE epitopes of Cyn d 1 is still
lacking. Studies of this nature are important because a siz-
able population is exposed and sensitized to BGP, and it
seems to be immunologically distinct from other clini-
cally important allergenic grasses. In light of the preva-
lence of BGP in warm tropical regions and its role as a
respiratory allergen, we focussed on identification of the
immunodominant regions of the major BGP allergen Cyn
d 1. To locate the relevant IgE binding regions on Cyn d 1,
a series of seven overlapping recombinant peptides and
three deletion mutants generated from the cDNA of Cyn
d 1 were investigated for their IgE binding capacity. We
report the presence of at least two major IgE binding
regions located within the C-terminus of Cyn d 1.
Methods
Pollen extract and patient sera
Human allergic sera were obtained from patients with a
clinical history and positive skin test reaction to Bermuda
grass pollen. Normal control serum samples were
obtained from healthy non-atopic subjects with a negative
skin test to BGP. BGP was obtained as dry, non-defatted
pollen from Greer Laboratories (North Carolina, USA).
Pollen extracellular proteins were extracted by incubation
in PBS (10 mM Na2HPO4, 1.8 mM KH2PO4, 140 mM
NaCl, 2.7 mM KCl, pH 7.4) for 10 min at room tempera-
ture with periodic stirring. The extract was filtered through
a Whatman No. 1 filter and centrifuged at 5000 g for 30
min at 4°C to separate the supernatant containing the
secreted protein. The serine protease inhibitor phenyl-
methylsulphonyl fluoride (PMSF [0.05% v/v]) was added
to the extract to prevent protein degradation due to pro-
tease activity. Both sera and pollen were stored at -20°C
until use.Clinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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Isolation of messenger RNA from Cynodon pollen
Cynodon dactylon pollen was purchased from Greer Labo-
ratory (North Carolina, USA). Total RNA was isolated
from 500 mg pollen using a slightly modified guanidine
hydrochloride method described by Logemann and co-
workers [23]. Pollen grains were finely ground in liquid
nitrogen, and mixed in 5 mL of extraction buffer (7.5 M
guanidine HCl in 0.1 M β-mercaptoethanol, 0.5% w/v
lauryl sarcosinate and 25 mM sodium citrate) prepared in
diethyl pyrocarbonate (DEPC) treated water. The extract
was centrifuged at 12,000 g for 20 min. The supernatant
was collected and purified twice with equal volume of
phenol: chloroform: isoamylalcohol (25:24:1 v/v) fol-
lowed by centrifugation. The RNA was treated with DNase
and the quality was analysed by agarose gel electrophore-
sis. Aliquots were stored at -70°C. Poly (A) messenger
RNA was affinity purified using oligo-dT cellulose (Micro-
fast trak Invitrogen), following the manufacturer's instruc-
tions.
Construction and immunoscreening of the Bermuda grass 
pollen cDNA library
Double-stranded cDNA was synthesized from purified
mRNA using a synthesis kit (Pharmacia LKB, Uppsala,
Sweden) according to manufacturer's instructions. The
cDNA was ligated to an Eco R1/Not 1 adaptor, cloned into
a Lambda gt 11 vector (Amersham), and packaged into
bacteriophages (Gigapak Gold III Stratagene) to construct
a cDNA expression library. E. coli Y1090 competent cells
were transduced with in vitro packaged phages, which
resulted in a primary library with 98% recombinant
clones. The cDNA library was screened with anti-Cyn d 1
mouse mAb 3A2, which binds Cyn d 1. Screening of the
cDNA library was carried out by taking plaque lifts and
probing with mAb 3A2. Briefly, lambda-gt11 phage with
the cDNA inserts were used to infect E. coli Y1090 cells,
plated onto LB plates (density 200–300 plaques/plate)
containing 100 μg/mL ampicillin and incubated at 42°C
for 4 h. The plates were overlaid with nitrocellulose filters
(Hybond-C extra, Amersham, U.K.) soaked with 1 mM
IPTG (isopropyl-β-D-thiogalacto-pyranoside) and incu-
bated at 37°C in order to induce the expression of fusion
protein. Two lifts were taken from each plate at 4-hour
intervals. Subsequently, the membranes were washed
with PBS-Tween20, blocked with 10% skim milk powder
in PBS and incubated with mAb 3A2 (1:1000 in 1% BSA/
PBS) for 5–6 hours. The membranes were washed with
PBS-0.05% Tween20 and incubated with alkaline phos-
phatase conjugated anti-mouse IgG, 1:1000 (Sigma) at
room temperature for 2 h. The positive clones were
selected by colorimetric development of membranes with
0.4 mmol/L nitroblue tetrazolium (Boehringer, Man-
nheim, Germany), 0.4 mmol/L 5-bromo-4-chloro-3-
indolyl phosphate p-toluidine salt (Astral Scientific, NSW,
Australia). The plaques for positive clones were excised
and further verified by secondary screening.
Isolation of Lambda DNA of positive clones
Lambda lysates were prepared by incubating an isolated
plaque with 500 μL of plating E. coli Y1090 cells for 15
min, after which the volume was made up to 5 mL with
LB containing 100 μg/mL ampicillin, 5 mM calcium chlo-
ride, 0.4% w/v maltose and the culture incubated at 37°C,
with shaking, for 5 h or until the bacterial cells were lysed;
thereafter 500 μL of chloroform was added to each culture
and incubated for a further 15 min. Bacterial debris was
removed by centrifugation at 8000 g for 10 min. The
lambda lysate was treated with DNase (10 μg/ml) and
RNase (20 μg/ml) at 37°C for 30 minutes to remove
traces of bacterial genomic DNA and RNA. Lambda DNA
was isolated twice from liquid lysates with an equal vol-
ume of phenol: chloroform: isoamylalcohol (25:24:1 v/v)
and the suspension gently mixed for 20 minutes followed
by centrifugation at 12,000 g for 20 minutes at 4°C. Final
extraction was carried out with equal volume of chloro-
form: isoamylalcohol (24: 1). The supernatant was trans-
ferred to a fresh tube and RNA was precipitated with 1/10
volume of 3 M sodium acetate and equal volume of cold
isopropanol. The mixture was stored at -20°C and DNA
pellet was recovered by centrifugation at 4°C for 20 min-
utes at 12,000 g. The pellet was washed with 70% ethanol,
vacuum dried and dissolved in TE buffer (pH 7.4).
Cloning and Sequencing of positive cDNA clones
The cDNA inserts of various clones were identified by PCR
with lambda-gt11 forward and reverse primers on purified
DNA template. The resulting PCR products were gel puri-
fied (Jetsorb Kit, Astral Scientific) and sub-cloned into
pGEM-T vector (Promega). Identity of the clones was ver-
ified by automated sequencing (Applied Biosystems,
USA) using T7 and SP6 DNA sequencing primers. The
nucleotide sequence and deduced amino-acid sequences
were compared by FASTA with those in the GeneBank
database. Sequence alignments were performed with the
CLUSTAL W package.
PCR cloning of rCyn d 1 and its derived, overlapping 
fragments and deletion mutants
Figure 1 shows the schematic diagram of the strategy for
the generation of the cDNA fragments. The 7 overlapping
fragments spanning the entire rCyn d 1 allergen sequence
were amplified by PCR and restriction sites were intro-
duced at both ends. The inserts were cloned as Stu1/Hind
III-fragments in the correct reading frame downstream
from the 6× His tag sequence of the pQE30Xa vector (Qia-
gen). The deletion mutants were cloned into the Bam H1
and Hind III restriction sites on the vector. Primer
sequences for preparing the constructs are provided in
Table 1. PCR was performed with 1 ng of DNA templateClinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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using thirty cycles of amplifications. PCR products were
analysed on agarose gels and purified using a Jetsorb kit
(Astral Scientific). Purified deletion fragments were sub-
cloned into the expression vector pQE30Xa (Qiagen) and
expressed as hexa-histidine fusion proteins in E. coli M15
cells (Qiagen).
Expression and purification of recombinant Cyn d 1 and of 
Cyn d 1 fragments and deletion mutants
Briefly, a 250 mL volume of LB broth containing 50 mg/
ml kanamycin and 100 mg/mL ampicillin (Sigma
Aldrich) was seeded with 5 ml overnight culture of E. coli
M15 cells (Qiagen) harbouring the expression plasmid
with either the entire Cyn d 1 cDNA, or the seven overlap-
ping fragments and three deletion mutants. The cultures
were grown at 37°C to log phase with an optical density
of A600 = 0.6. Isopropyl-βD-thiogalactoside (IPTG) (Pro-
gen) was added to a final concentration of 1 mM to induce
expression of the fusion protein. Following incubation at
37°C for a further 3 hours, bacterial cells were harvested
by centrifugation at 10,000 g for 20 minutes. The cell pel-
let from 1 mL of culture was resuspended in 100 uL of
reducing SDS sample buffer and subjected to SDS-PAGE
to evaluate expression levels. Cells were harvested from
the culture samples by centrifugation and stored at -20°C.
The cells were lysed by repeated freeze thaw cycles in liq-
uid nitrogen. The partially lysed cells were then resus-
pended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl,
10 mM imidazole pH 8.0). Lysozyme (Sigma, Aldrich) at
1 mg/ml was added to the resuspension, which was incu-
bated on ice for 30 minutes for further cell lysis. RNase A
(Sigma, Aldrich) at 10 μg/ml and DNase (Sigma, Aldrich)
at 5 μg/ml was added to the lysate and incubated for 15
minutes to remove bacterial RNA and DNA and to reduce
the viscosity of the cell lysate. The lysate was then centri-
fuged at 10,000 g for 20 min at 4°C. The supernatant was
collected and added to 1 mL TALON Ni-NTA resin (Clon-
tech, USA) to allow the resin to bind to the His tagged
recombinant protein. The mixture was rocked gently on
ice for 1 hour. The resin and supernatant mixture was
pipetted into a 1 mL column, (Qiagen) and the column
was allowed to settle by gravity before washing with a fur-
ther two column volumes of wash buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0).
Mapping of IgE binding regions on rCyn d 1 Figure 1
Mapping of IgE binding regions on rCyn d 1. Schematic location of the recombinant fragments and deletion mutants on 
the complete rCyn d 1 fragment. The dotted unfilled bars represent the deleted portions on the rCyn d 1 molecule.
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Fusion proteins were eluted from the column with several
aliquots of 0.5 mL of elution buffer (50 mM NaH2PO4,
300 mM NaCl, 250 mM imidazole, pH 8.0). The purity
and yield of the fusion proteins were established on
12.5% Coomassie stained SDS-PAGE gels. Concentra-
tions were measured at OD280.
Human IgE Dot blot analysis
To test the specific IgE-binding capacity of the recom-
binant peptides and deletion mutants, an immuno dot-
blot assay was performed. Varying concentrations (300,
400 and 500 nM) of purified recombinant proteins were
applied to a polyvinyl difluoride (PVDF) membrane with
a Minifold I Apparatus through vacuum suction. The dot-
blots were blocked with PBS (pH 7.4) containing 10%
skim milk for 1 h to block free binding sites. Both pooled
and individual allergic sera were diluted to 1:5 in PBS and
incubated with the dot-blots overnight at 4°C. Incubation
of the membranes with the secondary antibody was per-
formed with a 1:1000 dilution of alkaline phosphatase
conjugated mouse anti-human IgE (Sigma) for 1 h. The
bound human IgE was detected by incubating with 0.4
mmol/L nitroblue tetrazolium (Boehringer, Mannheim,
Germany), 0.4 mmol/L 5-bromo-4-chloro-3-indolyl
phosphate p-toluidine salt (Astral Scientific, NSW, Aus-
tralia) colorimetric substrates, and allowing the color sig-
nal on the membranes to develop. The membranes were
extensively washed with PBS containing 0.1% Tween 20
after each step throughout the protocol.
Direct ELISA of deletion mutants
The relative binding of IgE to deletion mutants and full-
length rCyn d 1 was assessed in an ELISA assay. Briefly,
microtiter 96-well plates (Maxisorp, Nunc, Denmark)
were coated with 5 ug/well of rCyn d1 and deletion
mutant proteins diluted in 0.1 M sodium bicarbonate
coating buffer (pH 9.6) for O/N incubation at 4°C. Opti-
mum concentrations of allergen and antibody were deter-
mined by checkerboard titration. Non-specific binding
sites were blocked by incubating with 200 μl per well of
blocking buffer (PBS, 0.05% Tween20 and 1% BSA) for 1
h at room temperature. After five washes with PBS con-
taining 0.05% Tween20, pooled and individual sera from
BGP allergic or non-allergic individuals (1:5) were added
to each well and incubated O/N at 4°C. The alkaline
phosphatase conjugated secondary antibody, mouse anti-
human IgE (Sigma), diluted 1:1000 in PBS/0.05% Tween
20/, 1% BSA was added to the wells and incubated for 3 h
at room temperature. The bound human IgE on the wells
was detected by addition of 0.1% pNPP p-nitro-phenyl
phosphate (Sigma) colorimetric substrate. The optical
density was measured at 405 nm. PBS buffer and sera
from non-allergic subjects were included in the assay as
negative controls.
Results
cDNA sequence analysis of Cyn d 1
A cDNA expression library was constructed from mRNA of
BGP in λ gt11 vector. E. Coli Y1090 was transduced with
in vitro packaged phages, which resulted in a plaque form-
ing unit per millilitre of 2.2 × 106 in the primary library
containing 98% recombinant clones. The library was
plated at a density of 50,000 plaque forming units per 20-
cm plate. A population of approximately 350,000 recom-
binant plaques were screened with anti-Cyn d 1 mouse
monoclonal antibody mAb3A2, which selectively binds
to group 1 grass pollen allergens. A cDNA encoding the
full length Cyn d 1 gene with an open reading frame
(ORF) of 786 base pairs (bp) starting with an ATG initia-
tion codon and terminating with a TGA stop codon was
isolated and its sequence is shown in Figure 2. The Open
Reading Frame encoded a mature protein of 244 amino
acids. A homology search of the nucleotide database
revealed a 100% nucleotide sequence identity of Cyn d 1
cDNA with a clone in the genbank database (GenBank
Database accession number AF177379) reported by Au
and colleagues as an acidic isoallergen of Cyn d 1 gene
[13]. This was followed by 96% sequence identity with
Cyn d 1 encoding clones AF177378 and AF177380 and
93% identity with clones AF159703 and AF177030. The
clone isolated from our library had the N-terminal amino
acid sequence AMGDKP and was likely an acidic isoaller-
Table 1: Sequence of primers used for cloning rCyn d 1 and of 
Cyn d 1 fragments and deletion mutants in expression vector 
pQE30Xa.
Primer Name Sequence (5' – 3')
λgt11Fwd GGTGGCGACGACTCTGGAGCCCG
λgt11Rev TTGACACCAGACCAACTGGTAATG
pQEFwd GTGAGCGGATAACAATTTCACACAG
pQERev GTTCTGAGGTCATTACTGGATC
F1Rev CCATCCTTAAGCTTGAAGATGGGTTCGTTG
F2Rev GATGAGGACAAGCTTGGGCTCGCCGGAGC
F3Rev CTCCTCTCCAAGCTTCTTCTTGGCCCATGGC
F4Rev GCCATCGCCAAGCTTGGCAGCGTACTTCAC
F5Fwd GTGAAGTACAGCGCTGCCGGCGATGGCAAC
F6Fwd CTGCGCAAGAGCGCTGGCGAACTGATG
F7Fwd GCAAGGAGCCCAGCGCTGAGTGCTCCGGC
F8CynFwd GGCGCATGGAGCGCTATGGGCGACAAGCCG
F8CynRev GCATCAATGCAAGCTTTCAGAACTGGATC
D120Fwd CTCCTCTCCGGATCCCTTCTTGGCCATGGC
D170Fwd GTGAAGTACGCTGGATCCGCCGGCGATGGC
D224Rev GACATCGTCCTGAAGCTTTTCGACATGGCC
The sequences of the 7 overlapping fragments of varying lengths 
covering the entire rCyn d 1 allergen molecule (previously cloned 
from the cDNA expression library) were amplified using specific 
primers designed to introduce restriction sites at both ends and were 
inserted as Stu1/Hind III-fragments in the correct reading frame 
downstream from the 6× His tag encoding gene sequence of the 
pQE30Xa vector. The deletion mutants were cloned using the Bam 
H1 and Hind III restriction sites on the expression vector. Restriction 
enzyme sites are italicised and in bold.Clinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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Nucleotide sequence of Cyn d 1 and its deduced amino acid sequence Figure 2
Nucleotide sequence of Cyn d 1 and its deduced amino acid sequence. The amino acid residues are numbered on the 
right. The amino acid numbering starts at the N-terminal amino acid, alanine of Cyn d 1. The putative pre-peptide (signal pep-
tide) consists of amino acid residues -18 to -1. The putative N-glycosylation site is underlined. Asterisk indicates the stop 
codon.
 
                     atgctcgcggcggtggcggtggtgctggcatcaatggtc 
                      M  L  A  A  V  A  V  V  L  A  S  M  V  
                     -18                
ggcggcgcatggtgtgccatgggcgacaagccgggccccaacatcactgcaacctacggt 
 G  G  A  W  C  A  M  G  D  K  P  G  P  N  I  T  A  T  Y  G  
            -1  +1                                        15 
gacaagtggctggatgcgaaggccacgttctacggcagcgacccacgtggcgcggccccc 
 D  K  W  L  D  A  K  A  T  F  Y  G  S  D  P  R  G  A  A  P  
                                                          35 
gacgaccacggcggcgcgtgcggatacaaggatgtcgacaaggcacccttcgacggcatg 
 D  D  H  G  G  A  C  G  Y  K  D  V  D  K  A  P  F  D  G  M  
                                                          55 
accggatgcggcaacgagcccatcttcaaggacggtctgggctgcggctcctgctacgag 
 T  G  C  G  N  E  P  I  F  K  D  G  L  G  C  G  S  C  Y  E  
                                                          75 
atcaagtgcaaggagcccgccgagtgctcaggtgagcccgtcctcattaagatcactgac 
 I  K  C  K  E  P  A  E  C  S  G  E  P  V  L  I  K  I  T  D  
                                                          95 
aagaactacgagcacatcgccgcctaccacttcgacctttctggcaaggcgttcggtgcc 
 K  N  Y  E  H  I  A  A  Y  H  F  D  L  S  G  K  A  F  G  A  
                                                          115 
atggccaagaagggcgaggaggacaagctgcgcaaggccggcgagctgatgctgcagttc 
 M  A  K  K  G  E  E  D  K  L  R  K  A  G  E  L  M  L  Q  F  
                                                          135 
cgccgcgtcaagtgcgagtacccgtccgacactaagatcaccttccacgtcgagaagggc 
 R  R  V  K  C  E  Y  P  S  D  T  K  I  T  F  H  V  E  K  G  
                                                          155 
tccagccccaattacctggcgctgctcgtgaagtacgccgccggcgacggcaacatcgtc 
 S  S  P  N  Y  L  A  L  L  V  K  Y  A  A  G  D  G  N  I  V  
                                                          175 
ggtgtcgacatcaagcccaagggctccgacgtgttccttcccatgaagctgtcatggggc 
 G  V  D  I  K  P  K  G  S  D  V  F  L  P  M  K  L  S  W  G  
                                                          195 
gccatctggaggatggacccccccaagccgctcaagggtcccttcaccatccgcctcacc 
 A  I  W  R  M  D  P  P  K  P  L  K  G  P  F  T  I  R  L  T  
                                                          215 
agcgagagtggcggccatgtcgaacaggaagatgttatccccgaagactggaagcccgac 
 S  E  S  G  G  H  V  E  Q  D  D  V  I  P  E  D  W  K  P  D  
                                                          235 
accgtctacaagtccaagatccagttctga 
 T  V  Y  K  S  K  I  Q  F  *   
                            244 Clinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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gen with a deduced molecular weight of 27 kDa according
to the classification by Au and colleagues [13]. The
sequence of residues -18 to -1, which leads to the N-termi-
nal, is composed of hydrophobic amino acids and repre-
sents the signal peptide. The motif Asn-X-Ser/Thr
(underlined) at amino acid residues +9 to +11 is a puta-
tive glycosylation site. This full-length Cyn d 1 clone was
used as the template for expressing recombinant Cyn d 1
protein and its derivatives for this study.
Expression and purification of rCyn d 1 and its derived 
fragments and deletion mutants
We derived a full-length Cyn d 1 fragment as a cDNA
clone by immunoscreening of a BGP lambda gt11 expres-
sion library with anti-Cyn d1 mouse mAb. The full-length
Cyn d 1 cDNA and the fragments were cloned into a
pQE30Xa expression vector and expressed as His-tagged
fusion protein in M15 cells. The expression of the recom-
binant fragments was determined by subjecting the bacte-
rial lysates to SDS PAGE followed by Coomassie Brilliant
blue staining. The expressed and purified recombinant
proteins showed bands with expected molecular mass as
shown in Figure 3. The length and location of the seven
overlapping fragments were F1 = 1 to 60, F2 = 1 to 90, F3
= 1 to 120, F4 = 1 to 170, F5 = 169 to 244, F6 = 129 to 244
and F7 = 83 to 244. The deduced molecular masses for
these recombinant peptides F1 to F7 were 6.1, 9.3,13, 19,
9, 13 and 19 kDa, respectively. Fragment 8, which is the
full-length rCyn d 1 was 244 amino acids long and had a
deduced molecular weight of 27 kDa. The expressed pro-
teins were affinity purified using a Ni-NTA resin column.
Three deletion mutants (D1, D2 and D3), missing parts of
the Cyn d 1 molecule, were prepared by PCR amplifica-
tion, expressed as His-tagged fusion proteins and affinity
purified. The overlapping fragments were designed so as
to cover the entire Cyn d 1 sequence with intervals of 30
to 50 residues. The seven overlapping fragments were
expressed and the crude bacterial lysates were subjected to
dot blot analysis to test for IgE binding. From the prelim-
inary dot blot assays, the additional 50 amino acid resi-
dues in F4 from F3 made it IgE reactive and therefore this
stretch of 50 residues appeared to be a potential epitope-
bearing region (data not shown). The C-terminal frag-
ment F5, consisting of only 74 residues, had the ability to
bind to IgE, indicating that residues 169–244 were impor-
tant for IgE reactivity. Furthermore, a study by Esch and
Klapper mapped an IgE binding site to the last 25 amino
acids at the C-terminal end of Lol p 1, a major group 1
allergen from Rye grass pollen with high sequence homol-
ogy to Cyn d 1 [24]. Based on the findings from the pre-
liminary dot blot assays and the study by Esch and
Klapper on Lol p 1, three deletion mutants D1, D2 and D3
were generated. A stretch of fifty amino acids, positioned
120 to 170, was removed in D1 since these additional res-
idues in F4 from F3 made it IgE reactive. The last twenty
residues (224–244) were removed to generate D2 based
on the IgE binding mapped to the last 25 residues of Lol
p 1 by Esch and Klapper [24] and a stretch of nucleotide
sequence where a restriction enzyme site could be easily
introduced. The third deletion mutant, D3, was a combi-
nation of D1 and D2, lacking both 50 residues from 120
to 170 as well as the last 20 residues from 224 to 244. The
Cyn d 1 deletion mutants showed molecular sizes of 20.9
kDa, 24.4 kDa and 18.5 kDa respectively as shown in Fig-
SDS PAGE of overlapping fragmets FI-F7, rCyn d 1 (F8) and deletion mutants D1–D3 Figure 3
SDS PAGE of overlapping fragmets FI-F7, rCyn d 1 (F8) and deletion mutants D1–D3. Recombinant proteins of 
the different fragments were expressed in M15 cells. The purified proteins were subjected to SDS PAGE and Coomassie stain-
ing. The arrows point to purified recombinant protein bands.
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ure 3. To further compare the IgE reactivity of the peptide
fragments and deletion mutants, the purified proteins
were subjected to IgE dot blot analysis and direct ELISA.
Dot blot analysis of Cyn d 1 fragments and deletion 
mutants
To evaluate the IgE-reactivity of purified whole rCyn d 1
(F8), overlapping peptide fragments (F1-7) and deletion
mutants (D1-3), the purified proteins were transferred
onto PVDF membranes and probed with four individual
and a pool of sera from 10 BGP allergic individuals. Three
concentrations (300, 400 and 500 nM) of the recom-
binant proteins were dotted onto the membrane. Purified
rCyn d 1 (F8) was used as the positive control, while PBS
buffer served as negative control. The dot blots comparing
the IgE binding of the recombinant fragments and dele-
tion mutants is shown in Figure 4. All of the sera from
BGP positive patients recognized intact rCyn d 1. IgE in
the sera from non-allergic individuals did not bind to
rCyn d 1 (data not shown). Peptide fragments F1 (1–60),
F2 (1–90) and F3 (1–120) did not bind to IgE. IgE bind-
ing to fragments F4 (1–170) and F5 (169–244) were weak
compared to complete rCyn d 1 fragment (F8), and the
positive IgE binding was heterogeneously distributed
among the different sera tested. Fragments F6 (129–244)
and F7 (83-24) showed IgE reactivity almost equal and
comparable to that of whole rCyn d 1 (F8). The deletion
mutants D1 and D2 showed significantly weak IgE reactiv-
ity while the third deletion mutant, D3, showed almost
complete depletion of IgE binding. The pattern of IgE
reactivity was similar for all the sera for F6, F7 and the
three deletion mutants. The immuno dot blotting results
indicate that the C-terminal region harbours the major IgE
binding domains (120–170 and 224–244) and is of most
diagnostic relevance.
IgE reactivity of rCyn d 1 deletion mutants by ELISA
A direct ELISA was performed to obtain a quantitative esti-
mation of IgE binding of the deletion mutants. The over-
lapping fragments were primarily used to localize the
regions on Cyn d 1 involved in IgE interaction. Once the
IgE binding regions had been identified, the deletion
mutants were subsequently generated and tested along-
side the fragments in IgE dot blot assays. The direct ELISA
was carried out on the deletion mutants to obtain a quan-
titative comparison of their IgE reactivity and the signifi-
cance of the deleted regions from each mutant in IgE
binding. Four individual sera and pooled sera from 10
grass pollen allergic patients were used to react with solid-
phase bound recombinant proteins. Serum from a non-
atopic donor and PBS buffer were used as negative con-
trols. The optical density was measured at 405 nm on an
ELISA plate reader, and the results are shown in Figure 5.
IgE from both individual and pooled sera bound strongly
to purified whole rCyn d 1. The percentage binding was
calculated using the OD readings obtained through direct
ELISA. The OD reading with whole purified rCyn d 1 was
expressed as 100% and the OD of the deletion mutants
were expressed in percentage relative to that of whole
rCyn d 1. The three deletion mutants were recognized by
patient IgE more weakly than the entire allergen molecule
in the following order: recombinant rCyn d 1 (100%) >
D2-(224–244)-(61.4 + 2.1%) > D1-(120–170)-(54.2 +
3.5%) > D3-(120–170 and 224–244)-(30.6 + 0.8%).
Pooled sera and individual patient sera P1, P3 and P4
showed slightly less binding to D1 than D2 except P2,
which reacted slightly more with D1 in comparison to D2.
The binding profile of all sera sets indicated close to 70%
reduction in IgE binding to D3, while D1 and D2 both
showed about 40% reduction in reactivity in comparison
to intact rCyn d 1. These data are summarized in Table 2.
These results further confirmed the presence of at least
two major IgE binding domains (120–170 and 224–244)
on Cyn d 1.
Discussion
In the present study, the cDNA of one of the most relevant
environmental aeroallergens, the major Bermuda grass
pollen allergen, Cyn d 1 (acidic isoform) was successfully
cloned and expressed to produce immunologically active
recombinant protein. No previous information was avail-
able on the clinically relevant epitopes on Cyn d 1. In the
present study, we identified the immunodominant
regions on the Cyn d 1 molecule. A collection of overlap-
ping fragments and deletion mutants were expressed
along with an N-terminal His tag and purified by Nickel
affinity chromatography. The purified proteins were sub-
jected to immuno dot blotting to compare their IgE reac-
tivity with sera from BGP allergic patients. Fragments F1,
F2 and F3, covering amino acid residues 1–120, failed to
show IgE Ab binding for all sera tested. IgE binding to
deletion mutants was weaker compared to intact rCyn d 1.
We identified at least two major IgE-binding regions
(120–170) and (224–244) by immunodot blot analysis.
To further determine the binding of deletion mutants to
IgE, a solid-phase ELISA was carried using four individual
sera and serum pool from 10 patients with BGP allergy.
Both deletion mutants D1 and D2 showed about 40%
reduction in IgE binding. Interestingly, deleting 50 resi-
dues (120–170) reduced IgE binding to about the same
extent as deleting the last 20 residues. The allergenic
potency of D3 devoid of both epitopes produced a signif-
icant reduction of about 70% in IgE binding in compari-
son to the whole molecule. These findings clearly
indicated that the C-terminal of Cyn d 1 was the major
IgE-binding region. Since removal of the two immunodo-
minant regions gave about 70% reduction in IgE reactivity
of rCyn d 1, other minor epitopes may be present that
account for the remaining 30% reactivity. The data
derived from our study are in agreement with IgE epitopesClinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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described from other grass group 1 allergens. The involve-
ment of C-terminal region in IgE binding has been
reported for the group 1 pollen allergens from several
grasses using either synthetic peptide fragments corre-
sponding to linear segments of the allergen or mono-
clonal antibody based mapping strategies [20-22].
Tamborini and co-workers mapped the IgE binding
region of Lol p 1, a major group 1 allergen from Rye grass
pollen. They produced three deletion mutants with large
deletions in the protein. The first mutant, lacking the N-
terminus region (aa 1–88), showed 27% IgE binding, the
second mutant, lacking region (aa 132–190), showed
Dot blot immunoscreening of the seven overlapping fragments (F1–F7), whole rCynd 1 and deletion mutants Figure 4
Dot blot immunoscreening of the seven overlapping fragments (F1–F7), whole rCynd 1 and deletion mutants. 
Dot blot immunoscreening of the seven overlapping fragments (F1–F7), whole rCynd 1 (F8) and deletion mutants (D1, D2, D3) 
with pooled sera from 10 patients and four individual patients with BGP allergy. Purified recombinant fusion proteins were 
applied onto PVDF membrane at 3 different concentrations (300 nM, 400 nM and 500 nM) and PBS buffer as negative control 
(NC).
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6.3% IgE reactivity, and the third mutant, missing the C-
terminus region (aa 116–240), showed 4.5% IgE reactiv-
ity as determined by ELISA. A strong reduction in IgE reac-
tivity was measured for the third mutant suggesting the C-
terminus as the immunodominant portion of Lol p 1
[25]. A similar approach using gene fragmentation and
synthetic peptides was used to map the IgE-binding
epitopes of major group 1 allergen of velvet grass pollen
Hol l 1 [21] and Phl p 1 from timothy grass [22]. The
binding patterns of patients' IgE to small peptides was
much weaker than to larger fragments, and 46% of sera
showed binding to C-terminus as opposed to only 8% of
sera binding to N-terminus region in the case of the Hol l
1 molecule [21]. The findings from B-cell epitope map-
ping studies of Phl p 1 were also similar to Hol l 1, with
the majority of sera recognizing the C-terminal fragment
rT147 that comprises amino acids 146 through 240 of Phl
p 1 [22]. The IgE-binding regions identified in Cyn d 1 in
the current study partially or completely overlap with
those identified in other Group 1 allergens where the C-
terminal portion has been shown to be immunodomi-
nant. The contention that this IgE containing region is
representative of group 1 allergens from other grass spe-
cies, and therefore is relevant for grass pollen allergy in
general, is supported by the fact that group 1 allergens
show very high sequence similarity (~85%). In addition,
this IgE containing regions has been reported to represent
Enzyme-linked immunosorbent assay data for serum immunoglobulin (Ig)E reactivity with whole recombinant Cyn d 1 and dele- tion mutants Figure 5
Enzyme-linked immunosorbent assay data for serum immunoglobulin (Ig)E reactivity with whole recombinant 
Cyn d 1 and deletion mutants. Enzyme-linked immunosorbent assay data for serum immunoglobulin (Ig)E reactivity with 
whole recombinant Cyn d 1 (unfilled bars) and deletion mutants D1 (grey bars), D2 (hatch bars) and D3 (square pattern bars) 
with four BGP positive individual sera (P1–P4) and allergic serum pool of 10 patients (Pool) and nonallergic serum pool of five 
normal subjects (Normal). OD values are expressed as mean from triplicate wells (± SEM).
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Table 2: Comparison of patients' IgE binding to rCyn d 1 and 
deletion mutants.
Sera rCyn d 1 D1 D2 D3
P1 100 47.7 59 29.5
P2 100 64.3 57 31.4
P3 100 59.1 68 30.3
P4 100 45.5 64.9 28.6
Pool n = 10 100 54.2 58.3 33.3
Mean ± SEM 54.2 ± 3.5 61.4 ± 2.1 30.6 ± 0.8
The percentages of IgE binding of deletion mutants relative to whole 
rCyn d 1 are shown for individual serum (P1–P4) and pooled patient 
sera (n = 10) as determined by ELISA. The percentage binding was 
calculated using the OD readings obtained through direct ELISA. The 
OD reading with whole purified rCyn d 1 was expressed as 100% and 
the OD of the deletion mutants were expressed in percentage 
relative to that of whole rCyn d 1. The mean ± SEM is shown in the 
bottom line.Clinical and Molecular Allergy 2009, 7:3 http://www.clinicalmolecularallergy.com/content/7/1/3
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prominent IgE epitope bearing region of grass group 1
allergens from other grass species.
The entire population of IgE epitopes for a number of aer-
oallergens has been shown to be dependent on their struc-
tural integrity. One of the approaches used to reduce the
anaphylactic potential of any allergen is to disrupt the
overall secondary structure of the protein. Since the
majority of IgE epitopes are known to be conformational,
a collapse in the structure can prevent allergen-specific IgE
recognition and cross-linking. In the extensively studied
Bet v 1 allergen from birch pollen expressing the molecule
as two separate fragments led to complete ablation of IgE
reactivity [26]. In case of the fragments generated for Cyn
d 1 in this study fragment 4 (aa 1–120), covering the
amino-terminal half of the molecule, did not bind IgE
while fragment 7 (aa 129–244), covering the C-terminal
end, showed positive reaction with IgE. These results sug-
gest that breaking the Cyn d 1 molecule into two halves
did not have a significant effect on IgE reactivity. The find-
ing that the majority of the IgE binding was preserved after
removing 120 residues from the N-terminal provides fur-
ther evidence for the C-terminus as a likely candidate rep-
resenting the major IgE binding region on Cyn d 1.
Based on the findings from this study, the lack of cross
reactivity of BGP extract with the Poeae grasses may seem
puzzling since most of the IgE antibodies are directed
against the C-terminal of the group 1 allergen across the
different grasses, including Cyn d 1. One possible expla-
nation for this phenomenon may be because several of
the earlier studies were carried out with crude pollen
extracts that comprised of a mixture of several allergenic
proteins making it difficult to obtain a detailed IgE profile
of the different allergenic fractions. Furthermore, three
dimensional structure and steric orientation of allergens
are crucial for cross-linking of mast cells and basophils-
bound IgE antibodies for inducing release of inflamma-
tory mediators. Spatial clustering of IgE-binding sites on
the Phl p 1 surface has been shown to be an important fac-
tor for its allergenic activity. Results from this study
defined a sterically oriented C-terminal fragment of Phl p
1 as the portion with highest allergenic activity [27].
Although group 1 allergens have high sequence identity,
point mutations of very few key amino acid residues can
drastically alter the protein structure and spatial orienta-
tion of the IgE epitope. For example, cysteine residues and
disulfide bonds play an important role in IgE binding in
the case of grass allergen Lol p 1. Replacement of cysteine
residue at position 77 with serine caused an average of
67.2% reduction in human IgE reactivity to this molecule
[28]. As discussed previously, even though the major IgE
epitope for group 1 allergen is located at the C-terminus,
there may be differences in the minor epitopes that could
influence the secondary structure of the protein. Altera-
tions of secondary structure may cause constraints on the
orientation of the molecule. Small changes in amino acid
sequence can alter a protein's structure that, in turn, can
affect mast cell induction and basophil activation. Studies
have demonstrated that isoforms of the same allergen
with very few amino acid differences can exhibit greatly
varying potencies to induce an allergic response. For
example, a naturally occurring low allergenic isoform has
been reported for hazel pollen allergen Cor a 1 [29]. Since
the crystal structure of Cyn d 1 protein has not been
solved, further studies are needed to finely map the IgE-
binding regions of Cyn d 1. Inhibition of IgE binding by
synthetic peptides representing homologous amino acids
sequences of other Poaeae grasses could provide a better
understanding of the precise distribution of IgE epitopes
on Cyn d 1 and their role in allergic sensitization. This
type of analysis should further elucidate the observed lack
of cross reactivity between BGP and pollen from Poae
grasses.
Conclusion
In conclusion, we describe here the results of an experi-
mental investigation that led us to identify at least two
major IgE binding regions on Cyn d 1, the major allergen
from Bermuda grass pollen. We mapped these binding
regions to the C-terminal end of the molecule. The loca-
tion of epitopes within the highly conserved C-terminus
of grass group 1 allergens may be a common feature of the
IgE response to grass group 1 allergens. Since structural
and mutational analyses of allergens can be utilized to
develop vaccines for allergy therapy, targeted substitution
or deletion of amino acids within the identified epitopes
could result in nonanaphylactic allergenic variants that
may, in turn, be useful to develop vaccines for BGP allergy
sufferers.
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